Some of the more common side effects of Cimzia (certolizumab pegol) include upper respiratory tract infection, UTI, and rash. Other mild and serious side effects are also possible. Cimzia can ...
Olaptesed pegol is under clinical development by TME Pharma and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase II drugs for Glioblastoma Multiforme (GBM) have ...
Thus there has been the development of a number of other biologic agents for use in RA including the new TNFi agents: certolizumab pegol (CZP) and golimumab. Experience [5] and randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback